|
Study | Study population | Blood pressure variability index | Outcome |
|
Kikuya et al. [50] | General population | Day-to-day systolic BPV | Increased hazard ratios for cardiovascular and stroke mortality |
Muntner et al. [51] | General population | Visit-to-visit systolic BPV | Increased all-cause mortality |
Johansson et al. [52] | General population | Day-to-day morning systolic BPV | Increased rate of cardiovascular events |
Hsieh et al. [53] | Patients with type 2 diabetes | Visit-to-visit systolic and diastolic BPV | Increased all-cause mortality |
Ushigome et al. [54] | Patients with type 2 diabetes | Day-to-day systolic and diastolic BPV | Development of macroalbuminuria |
Kilpatrick et al. [55] | Patients with type 1 diabetes | Annual visit-to-visit BPV | Development or progression of nephropathy |
Di Iorio et al. [56] | Subjects with chronic renal failure | Visit-to-visit systolic BPV | Elevated risk of death |
Yokota et al. [57] | Patients with nondiabetic chronic kidney disease | Visit-to-visit systolic BPV | Deterioration of renal function |
Di Iorio et al. [58] | Patients with end stage renal disease under hemodialysis | Dialysis-to-dialysis BPV | Increased cardiovascular mortality |
|